Montalvo G, Guzmán S, Muñoz W, Varela E, Melgarejo A, Niño-Cruz JA

Language: Spanish
References: 23
Page: 630-637
PDF size: 421.29 Kb.

ABSTRACT

The renal glomerulus highly vascularized structure is affected by a small vessel vasculitis group associated with neutrophil cytoplasmic antibodies (ANCA) described by its relative scarcity of pauci-immune deposits as immune. This vasculitis is classified according to international consensus in Chapel-Hill microscopic poliangetitis, granulomatosis with polyangiitis, eosinophilic granulomatosis and the called vasculitis limited to the kidney. From the anatomopathological point of view, the rapidly progressive glomerulonephritis can be divided into pauci-immune, anti glomerular basement membrane and mediated by immune complexes. The treatment is generally based on immunosuppressive therapy and renal therapy support from conservative measures to renal replacement therapy. This paper reports a case of rapidly progressive glomerulonephritis associated with ANCA pathological confirmation.

REFERENCES

1. Rowaiye OO, et al. The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J 2015;345-350.

2. Floege F, Amann K. Primary glomerulonephritides. Lancet Seminar 2016.

3. Cervera R, Espinosa G, Ramos-Casals M, Hernández- Rodríguez J y col. Diagnóstico y tratamiento de las enfermedades autoinmunes sistémicas. Hospital Clinic, Barcelona. Caduceo multimedia. 2012.

4. Bomback AS, et al. ANCA-associated glomerulonephritis in the very elderly. Kidney Int 2011 Apr;79(7):757-64. doi: 10.1038/ki.2010.489.

5. Abeer K, Warraich I, Prabhakar S. ANCA associated glomerulonephritis- an in-depth review. J Nephrol Ther 2013;4:1.

6. Haas M. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004;65(6):2145.

7. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110(7):955-963.

8. Porges AJ, Redecha PB, Kimberly WT, Csernok W, et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994;153(3):1271-1280.

9. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994;98(2):270-278.

10. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87(11):4115-4119.

11. Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997;8(3):386-394.

12. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kid Int 1992;41(2):375-383.

13. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nature Med 2009;15(6):623-625.

14. Gupta AK, Joshi MB, Philippova M, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Letters 2010;584(14):3193-3197.

15. Wilde B, Ewissen M, Damoiseaux J, et al. Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis 2013;72(8):1416-1419.

16. Sinico RA, et al. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 2013;12:477-482.

17. Agard C, et al. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature. Semin Arthritis Rheum 2007 Jun;36(6):386-91.

18. Goldfarb JM, et al. Head and neck manifestations of eosinophilic granulomatosis with polyangiitis: a systematic review. Otolaryngol Head Neck Surg 2016 Nov;155(5):771-778.

19. Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 2001 Dec;14(12):1284-93.

20. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int 2012; 2 Suppl):139-274.

21. Holdsworth SR, et al. Biologics for the treatment of autoimmune renal diseases. Nature Reviews Nephrol 2016.

22. Syed R, et al. Pauci-immune crescentic glomerulonephritis: An ANCA-associated vasculitis. BioMed Research International 2015.

23. Yates M, Watts RA, Bajema IM, Cid MC, et al; EULAR/ ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis June 23, 2016.